10.02.2015 Views

Graz University of Technology Austria Institute of Biochemistry ...

Graz University of Technology Austria Institute of Biochemistry ...

Graz University of Technology Austria Institute of Biochemistry ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

plant genes that apparently encode flavin-dependent oxidases. These genes are currently<br />

expressed in our laboratory in order to characterize the role <strong>of</strong> the enzymes in alkaloid<br />

biosynthesis (thesis project <strong>of</strong> Silvia Wallner).<br />

Dipeptidylpeptidase III<br />

Dipeptidyl-peptidases III (DPPIII; EC 3.4.14.4) are Zn-dependent enzymes with molecular<br />

masses <strong>of</strong> ca. 80-85 kDa that specifically cleave the first two amino acids from the N-<br />

terminus <strong>of</strong> different length peptides. All known DPPIII sequences contain the unique motif<br />

HEXXGH, which enabled the recognition <strong>of</strong> the dipeptidyl-peptidase III family as a distinct<br />

evolutionary metallopeptidase family (M49). In mammals, DPPIII is associated with<br />

important physiological functions such as pain regulation, and hence the enzyme is a potential<br />

drug target. Previously, Sigrid Deller and Nina Jajcanin-Jozic have successfully expressed,<br />

purified and characterized the recombinant yeast enzyme, and Pravas Baral in Karl Gruber’s<br />

laboratory at the Karl-Franzens-<strong>University</strong> has elucidated the crystal structure <strong>of</strong> the yeast<br />

protein. This work revealed that yeast DPPIII features a novel protein topology.<br />

Structure <strong>of</strong> human DPPIII in its open form (right) and peptide liganded (closed) form<br />

In collaboration with a structural genomics group in Toronto led by Dr. Sirano Dhe-Paganon,<br />

Gustavo Arruda has solved the structure <strong>of</strong> the human enzyme both in its open (right, above)<br />

and closed conformation (left, above). The latter structure was obtained by co-crystallization<br />

<strong>of</strong> a tightly binding peptide to an inactive variant <strong>of</strong> human DPPIII. These two new structures<br />

constitute a major breakthrough in our effort to understand the physiological role <strong>of</strong> the<br />

enzyme and pave the way for the development <strong>of</strong> potentially useful inhibitors <strong>of</strong> the enzyme<br />

(Gustavo Arruda’s thesis project in Pr<strong>of</strong>. Gruber’s laboratory supported by Alexandra Binter).<br />

9

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!